19,559 Shares in CVS Health Corporation (NYSE:CVS) Bought by Slagle Financial LLC

Slagle Financial LLC acquired a new stake in CVS Health Corporation (NYSE:CVS - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 19,559 shares of the pharmacy operator's stock, valued at approximately $1,325,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in CVS. Hopwood Financial Services Inc. acquired a new position in CVS Health during the fourth quarter worth approximately $29,000. McIlrath & Eck LLC grew its stake in CVS Health by 32.6% during the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after buying an additional 174 shares during the period. Park Square Financial Group LLC purchased a new stake in CVS Health during the fourth quarter worth approximately $43,000. PARK CIRCLE Co grew its stake in CVS Health by 42.9% during the fourth quarter. PARK CIRCLE Co now owns 1,000 shares of the pharmacy operator's stock worth $45,000 after buying an additional 300 shares during the period. Finally, Strategic Investment Solutions Inc. IL grew its stake in CVS Health by 77.2% during the fourth quarter. Strategic Investment Solutions Inc. IL now owns 1,024 shares of the pharmacy operator's stock worth $46,000 after buying an additional 446 shares during the period. Institutional investors and hedge funds own 80.66% of the company's stock.

CVS Health Price Performance

Shares of CVS traded down $0.29 during mid-day trading on Wednesday, hitting $66.65. The company's stock had a trading volume of 6,329,968 shares, compared to its average volume of 10,809,034. The firm has a 50-day moving average price of $65.18 and a 200 day moving average price of $61.90. The stock has a market capitalization of $84.31 billion, a price-to-earnings ratio of 15.91, a PEG ratio of 0.95 and a beta of 0.57. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.82 and a quick ratio of 0.63. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.63. The company had revenue of $94.59 billion for the quarter, compared to analysts' expectations of $93.07 billion. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The business's revenue was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.31 EPS. On average, research analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 1st. Shareholders of record on Tuesday, July 22nd will be issued a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.99%. The ex-dividend date is Tuesday, July 22nd. CVS Health's payout ratio is 63.48%.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on CVS. Cowen reiterated a "buy" rating on shares of CVS Health in a research note on Monday, May 5th. Royal Bank Of Canada upped their target price on shares of CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a research note on Monday, May 5th. Barclays set a $79.00 target price on shares of CVS Health and gave the company an "overweight" rating in a research note on Monday, June 2nd. Robert W. Baird upped their target price on shares of CVS Health from $51.00 to $71.00 and gave the company a "neutral" rating in a research note on Tuesday, April 15th. Finally, Jefferies Financial Group increased their price objective on shares of CVS Health from $74.00 to $80.00 and gave the company a "buy" rating in a research note on Monday, June 30th. Two equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $75.06.

Insider Activity at CVS Health

In other news, Director Guy P. Sansone bought 1,570 shares of the firm's stock in a transaction on Thursday, June 5th. The stock was bought at an average cost of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the acquisition, the director directly owned 12,007 shares in the company, valued at $764,845.90. This represents a 15.04% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. 1.22% of the stock is currently owned by insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.